HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.400
+0.250 (11.63%)
Mar 6, 2026, 3:59 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.37 billion as of March 6, 2026. Its market cap has increased by 129.63% in one year.
Market Cap
1.37B
Enterprise Value
1.05B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.40
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.37B, a decrease of -78.48%. That is a compound annual growth rate of -50.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.37B | -18.64% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.59B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.50B |
| Immunotech Biopharm | 1.45B |
| CANbridge Pharmaceuticals | 1.40B |
| Beijing Biostar Pharmaceuticals | 1.37B |
| Kintor Pharmaceutical | 1.26B |
| Shanghai Bio-heart Biological Technology | 1.12B |
| Wuhan YZY Biopharma | 1.10B |